Results
184
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
184 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
PGOLD New | ₱25.55 | 2.0% | -8.8% | ₱73.2b | ₱40.84 | PE8.2x | E10.8% | 7.0% | Consumer Retailing | ||
500265 New | ₹602.55 | -1.9% | -38.8% | ₹80.7b | ₹775.00 | PE10.2x | E4.4% | 1.7% | Materials | ||
2142 | HK$5.08 | 18.1% | 202.4% | HK$3.7b | n/a | PE22.3x | n/a | n/a | Pharmaceuticals & Biotech | ||
500460 New | ₹95.60 | -10.0% | -43.8% | ₹13.8b | n/a | PE14.7x | n/a | 2.1% | Materials | ||
SECB | ₱74.80 | -3.2% | 6.2% | ₱56.4b | ₱111.53 | PB0.4x | E16.7% | 4.0% | Banks | ||
AVIA New | Rp370.00 | -2.1% | -36.2% | Rp22.6t | Rp640.00 | PE13.6x | E9.4% | 5.9% | Materials | ||
CVSG | UK£10.90 | 7.1% | -34.9% | UK£782.0m | UK£14.10 | PE29.8x | E15.0% | 0.7% | Healthcare | ||
GAMA | UK£13.50 | -1.0% | 11.0% | UK£1.3b | UK£18.54 | PE22.9x | E14.0% | 1.3% | Telecom | ||
FRAN | UK£1.52 | 1.7% | -9.8% | UK£292.1m | UK£3.23 | PE40.6x | S7.9% | 1.5% | Commercial Services | ||
FOUR | UK£55.80 | -3.5% | 0.2% | UK£1.6b | UK£70.90 | PE17.8x | E1.8% | 2.9% | Media | ||
FOYRK | €4.33 | 0.9% | 1.9% | €216.6m | €5.70 | PE8.3x | E7.3% | 2.8% | Retail | ||
ABG | NOK 6.86 | -6.9% | 6.4% | NOK 3.6b | n/a | PE11.6x | n/a | 7.3% | Diversified Financials | ||
LOGIST | SEK 152.00 | 1.3% | n/a | SEK 1.1b | n/a | PE12.6x | n/a | 3.4% | Real Estate Management and Development | ||
SDY | UK£0.20 | 0.1% | -30.8% | UK£90.8m | UK£0.42 | PS0.2x | E89.9% | 13.2% | Capital Goods | ||
OPT | UK£1.75 | 1.2% | n/a | UK£155.4m | UK£2.12 | PS1.5x | E204.8% | n/a | Healthcare | ||
BYIT | UK£4.46 | -3.4% | -25.9% | UK£1.1b | UK£6.00 | PE20.7x | E7.2% | 4.0% | Software | ||
CMCO New | US$20.47 | -1.9% | -50.3% | US$586.0m | US$38.25 | PE62.6x | E78.3% | 1.4% | Capital Goods | ||
PMZ.UN | CA$15.44 | 5.8% | 12.0% | CA$1.6b | CA$18.31 | PB0.7x | E37.8% | 5.6% | Real Estate | ||
CDXC | US$5.91 | 7.5% | 271.7% | US$449.4m | US$7.96 | PE304.7x | E81.8% | n/a | Pharmaceuticals & Biotech | ||
CFW | CA$3.88 | -0.3% | -25.7% | CA$332.3m | CA$5.17 | PE11.8x | E34.6% | 0% | Energy | ||
FRAF | US$37.95 | 1.6% | 44.3% | US$167.3m | n/a | PB1.1x | n/a | 3.4% | Banks | ||
EFSI New | US$32.95 | 0% | 9.9% | US$114.2m | n/a | PB1x | n/a | 3.8% | Banks | ||
LMB New | US$85.49 | -9.1% | 101.5% | US$1.0b | US$115.33 | PE36.7x | E21.0% | n/a | Capital Goods | ||
FUNC | US$41.38 | -0.6% | 94.3% | US$261.2m | US$42.00 | PB1.5x | E14.0% | 2.1% | Banks |